[go: up one dir, main page]

GB201607940D0 - Personalised media - Google Patents

Personalised media

Info

Publication number
GB201607940D0
GB201607940D0 GBGB1607940.2A GB201607940A GB201607940D0 GB 201607940 D0 GB201607940 D0 GB 201607940D0 GB 201607940 A GB201607940 A GB 201607940A GB 201607940 D0 GB201607940 D0 GB 201607940D0
Authority
GB
United Kingdom
Prior art keywords
personalised
media
personalised media
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1607940.2A
Other versions
GB2543374B (en
GB2543374A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imagen Therapeutics Ltd
Original Assignee
Imagen Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imagen Therapeutics Ltd filed Critical Imagen Therapeutics Ltd
Publication of GB201607940D0 publication Critical patent/GB201607940D0/en
Publication of GB2543374A publication Critical patent/GB2543374A/en
Application granted granted Critical
Publication of GB2543374B publication Critical patent/GB2543374B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/80Undefined extracts from animals
    • C12N2500/84Undefined extracts from animals from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/11Epidermal growth factor [EGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB1607940.2A 2015-05-08 2016-05-06 Personalised media Active GB2543374B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1507894.2A GB201507894D0 (en) 2015-05-08 2015-05-08 Personalised media

Publications (3)

Publication Number Publication Date
GB201607940D0 true GB201607940D0 (en) 2016-06-22
GB2543374A GB2543374A (en) 2017-04-19
GB2543374B GB2543374B (en) 2018-11-07

Family

ID=53489330

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1507894.2A Ceased GB201507894D0 (en) 2015-05-08 2015-05-08 Personalised media
GB1607940.2A Active GB2543374B (en) 2015-05-08 2016-05-06 Personalised media

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB1507894.2A Ceased GB201507894D0 (en) 2015-05-08 2015-05-08 Personalised media

Country Status (2)

Country Link
GB (2) GB201507894D0 (en)
WO (1) WO2016181114A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108707582A (en) * 2018-05-24 2018-10-26 上海赫佰生物医药科技有限公司 A kind of high-efficient culture method and its application of the tumour cell in body fluid source

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443546A (en) * 1980-07-07 1984-04-17 The Beth Israel Hospital Association Process and composition for propagating mammalian cells
US20040077079A1 (en) * 2001-01-31 2004-04-22 Peter Storgaard Improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
KR100908481B1 (en) * 2006-04-24 2009-07-21 코아스템(주) Mesenchymal stem cell culture medium and culture method of mesenchymal stem cells using the same
CN102459574B (en) * 2009-06-18 2016-06-29 塞拉提斯股份公司 Growth and the 3D culture systems of differentiation for dry (hPS) cell of people's pluripotency
NZ709124A (en) * 2009-10-30 2017-06-30 Univ North Carolina Chapel Hill Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same
DE102009047146B4 (en) 2009-11-25 2012-07-19 Ulrich Pachmann A method for predicting the response of a tumor disease to a therapeutic intervention
IT1408248B1 (en) * 2011-02-11 2014-06-13 Fond I R C C S Istituto Neurologico Carlo Besta CULTURAL LAND AND METHOD FOR EXTRACTION, ISOLATION AND PROPAGATION OF ENDYELIAL ANIMALS WITH HIGH PURITY ANIMALS AND HIGHLY PURIFIED CONTINUOUS ANIMAL CELL LINES SO OBTAINED
WO2012131733A2 (en) * 2011-03-31 2012-10-04 Godavari Biorefineries Limited Media compositions, method of initiating and enriching cultures of stem cells and/or cancer stem-like cells
JP6147259B2 (en) * 2011-10-04 2017-06-14 ミトラ アールエックスディーエックス インディア プライベート リミテッドMitra Rxdx India Private Limited ECM composition, tumor microenvironment platform and method thereof
WO2013069010A1 (en) 2011-11-10 2013-05-16 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods for individually optimizing a cancer treatment
WO2014114465A1 (en) * 2013-01-24 2014-07-31 Bernardo Nadal-Ginard Modulation of cardiac stem-progenitor cell differentiation, assays and uses thereof
EP3004394A4 (en) 2013-06-04 2016-12-21 Univ Miami ASSAYS, METHODS AND KITS FOR ANALYZING SENSITIVITY AND RESISTANCE TO ANTICANCER DRUGS, GIVING PROGNOSTIC CANCER PATIENT, AND PERSONALIZED THERAPEUTIC STRATEGIES
US10473646B2 (en) * 2014-05-26 2019-11-12 Universitaetsspital Basel In vitro culturing or expanding human or animal tissue
WO2016154082A2 (en) * 2015-03-23 2016-09-29 Tang Yao Methods of primary tissue culture and drug screening using autologous serum and fluids

Also Published As

Publication number Publication date
WO2016181114A1 (en) 2016-11-17
GB2543374B (en) 2018-11-07
GB2543374A (en) 2017-04-19
GB201507894D0 (en) 2015-06-24

Similar Documents

Publication Publication Date Title
GB2558478B (en) Copy-Redirect on write
GB2521883B (en) Media controller
GB2538755B (en) Media routing
EP3119611A4 (en) Printable media
GB201614356D0 (en) Media buffering
GB201513196D0 (en) Media device
GB201403568D0 (en) Dense media deparation method
ZA201606446B (en) Filter media construction
GB201408653D0 (en) Moonpool
GB201405948D0 (en) Enhanced media quality management
GB201607575D0 (en) Augmented media
EP3294560A4 (en) Printable media
EP3265321A4 (en) Printable media
EP3198471A4 (en) Media organization
IL267558B (en) Perfusion media
GB2537722B (en) Booklet
GB201517358D0 (en) Media filter
PL3183486T3 (en) Preassembled media line
GB201401171D0 (en) Purification medium
GB2543374B (en) Personalised media
GB201620722D0 (en) Media streaming system
GB201615253D0 (en) Media
GB201506424D0 (en) Personalised contact
GB201503807D0 (en) Personalised mattress
GB201613815D0 (en) Adaptive media combined with medicines